Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “S. Pneumoniae Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00861744
What this trial is testing

Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age

Who this might be right for
RubellaMumpsMeasles+1 more
GlaxoSmithKline 1,259
Not applicableStudy completedNCT01787838
What this trial is testing

Improving Pneumococcal Vaccination Rates in an Ambulatory Pre-surgical Testing Setting

Who this might be right for
Community Acquired Pneumonia
Carilion Clinic 2,509
Post-approval studies (Phase 4)Study completedNCT03619252
What this trial is testing

Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents

Who this might be right for
Multiple MyelomaPneumococcal InfectionFebrile Neutropenia+1 more
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology 36
Testing effectiveness (Phase 2)Study completedNCT00169234
What this trial is testing

Pneumococcal Adult-dose Ranging Immunization Study

Who this might be right for
Pneumonia
Kaiser Permanente 220
Early research (Phase 1)Not Yet RecruitingNCT06970756
What this trial is testing

A Phase I Clinical Study to Evaluate the Safety of PCV26 in Individuals ≥60

Who this might be right for
Pneumococcal Diseases
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 60
Large-scale testing (Phase 3)Not Yet RecruitingNCT07832500
What this trial is testing

A Lot-to-Lot Consistency Clinical Trial of PCV13

Who this might be right for
Pneumococcal Infectious Diseases
Sinovac Life Sciences Co., Ltd. 1,125
Early research (Phase 1)Study completedNCT01444339
What this trial is testing

Study of Two Investigational Pneumococcal Vaccines in Healthy Adults

Who this might be right for
Pneumococcal InfectionsStreptococcus Pneumoniae InfectionsPneumococcal Pneumonia
Sanofi 131
Post-approval studies (Phase 4)Study completedNCT05329259
What this trial is testing

Describe the Safety of a Vaccine (Called 13vPnC) in Healthy People 18 to 49 Years of Age in India

Who this might be right for
Pneumococcal Disease
Pfizer 200
Not applicableStudy completedNCT05173727
What this trial is testing

Prevalence and Serotype of Streptococcus Pneumoniae Hospitalized Adult With Community-Acquired Pneumonia

Who this might be right for
Pneumonia, Bacterial
Dr Cipto Mangunkusumo General Hospital 355
Large-scale testing (Phase 3)Study completedNCT01641133
What this trial is testing

Primary Vaccination With Either Synflorix™ or Prevenar 13™ or Both Vaccines and Booster Vaccination With Synflorix™

Who this might be right for
Infections, StreptococcalStreptococcus Pneumoniae Vaccines
GlaxoSmithKline 457
Early research (Phase 1)Study completedNCT01444352
What this trial is testing

Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adults

Who this might be right for
Pneumococcal InfectionsStreptococcus Pneumoniae InfectionsPneumococcal Pneumonia
Sanofi Pasteur, a Sanofi Company 100
Post-approval studies (Phase 4)Study completedNCT00371878
What this trial is testing

Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Lung Fluid of Adults With and Without HIV Infection

Who this might be right for
PneumoniaMeningitisInvasive Pneumococcal Disease+1 more
Royal Liverpool University Hospital 40
Testing effectiveness (Phase 2)WithdrawnNCT01443117
What this trial is testing

Evaluating the Safety and Immune Response to Two Pneumococcal Vaccines in HIV-Infected Pregnant Women

Who this might be right for
Pneumococcal InfectionsHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableStudy completedNCT02266277
What this trial is testing

System Alignment for VaccinE Delivery (SAVED): Improving Rates of Influenza and Pneumococcal Vaccination Through Patient Outreach, Improved Medical Record Accuracy and Targeted Physician Alerts

Who this might be right for
InfluenzaInfections, Pneumococcal
University of Massachusetts, Worcester 30,000
Not applicableStudy completedNCT03350425
What this trial is testing

Duration of Protection From Pneumonia After Pneumococcal Vaccination in Hemodialysis Patients

Who this might be right for
CKD (Chronic Kidney Disease) Stage 5DPneumonia
University of Cologne 792
Not applicableActive Not RecruitingNCT06096025
What this trial is testing

Short Versus Long Duration of Therapy for Streptococcus Pneumoniae Bloodstream Infections

Who this might be right for
Streptococcus Pneumoniae
Methodist Health System 200
Not applicableStudy completedNCT06638333
What this trial is testing

Prevalence and Serotype Distribution of Streptococcus Pneumoniae in Healthy Vietnamese Children From 6 Months to 5 Years Old

Who this might be right for
Streptococcus Pneumonia
Tam Anh Research Institute 800
Large-scale testing (Phase 3)Study completedNCT01734239
What this trial is testing

A Phase III Clinical Trial to Study the Safety and Immunogenicity of Pneumovax™ 23 (V110) in Participants From the Russian Population (V110-018)

Who this might be right for
Pneumococcal Disease
Merck Sharp & Dohme LLC 102
Testing effectiveness (Phase 2)Study completedNCT00985751
What this trial is testing

Safety & Immunogenicity of Pneumococcal Vaccine 2189242A in Children Aged 12-23 Months at the Time of First Vaccination

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline 257
Large-scale testing (Phase 3)Study completedNCT03571607
What this trial is testing

A Safety And Immunogenicity Study Of A 13-valent Pneumococcal Conjugate Vaccine In Japanese Subjects Aged 6 To 64 Years.

Who this might be right for
Pneumococcal Infections
Pfizer 206
Next Page